lapatinib has been researched along with doxorubicin hydrochloride in 2 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (doxorubicin hydrochloride) | Trials (doxorubicin hydrochloride) | Recent Studies (post-2010) (doxorubicin hydrochloride) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 277 | 0 | 205 |
| Protein | Taxonomy | lapatinib (IC50) | doxorubicin hydrochloride (IC50) |
|---|---|---|---|
| RNA polymerase beta subunit (EC 2.7.7.6), partial | Escherichia coli | 14.3747 | |
| 90-kda heat shock protein beta HSP90 beta, partial | Homo sapiens (human) | 0.266 | |
| Apoptotic peptidase activating factor 1 | Homo sapiens (human) | 21.2 | |
| TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | 12.7 | |
| caspase-9 isoform alpha precursor | Homo sapiens (human) | 34.6 | |
| caspase-3 isoform a preproprotein | Homo sapiens (human) | 34.6 | |
| heat shock protein HSP 90-alpha isoform 2 | Homo sapiens (human) | 0.266 | |
| 14-3-3 protein gamma | Homo sapiens (human) | 0.7812 | |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | 0.94 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cai, Z; Ghaleb, H; Huang, W; Jiang, Y; Liu, Y; Qian, H; Qiu, Q; Shi, W; Yin, Z; Zhang, P; Zhou, J; Zou, F | 1 |
2 other study(ies) available for lapatinib and doxorubicin hydrochloride
| Article | Year |
|---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Exploration of novel phthalazinone derivatives as potential efflux transporter inhibitors for reversing multidrug resistance and improving the oral absorption of paclitaxel.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Neoplasm Proteins; Neoplasms; Paclitaxel | 2022 |